Mirikizumab phase 2 in CD
Safety and tolerability of spesolimab in UC
Steroid exposure and perinatal outcomes
Vedolizumab in perianal CD
Low-dose azathioprine and allopurinol in UC
Barrier healing in IBD
Obefazimod in mod-severe UC
Risankizumab maintenance of remission in CD
Risankizumab in CD
Guselkumab in CD